ChemicalBook >> CAS DataBase List >>Samalizumab
Samalizumab
- CAS No.
- 1073059-33-2
- Chemical Name:
- Samalizumab
- Synonyms
- Samalizumab;Samalizumab (anti-CD200);Research Grade Samalizumab;Research Grade Samalizumab (DHE30301)
- CBNumber:
- CB33143871
- Molecular Formula:
- Molecular Weight:
- 0
- MDL Number:
- MOL File:
- Mol file
- MSDS File:
- SDS
- TDS File:
- TDS
Last updated:2026-04-24 14:58:44
| form | Liquid |
|---|---|
| color | Colorless to light yellow |
| FDA UNII | 64EUX713G6 |
| NCI Drug Dictionary | samalizumab |
Samalizumab price
| Manufacturer | Product number | Product description | CAS number | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|---|
| ChemScene | CS-0624059 | Samalizumab 99.94% | 1073059-33-2 | 1mg | $325 | 2026-06-04 | Buy |
| ChemScene | CS-0624059 | Samalizumab 99.94% | 1073059-33-2 | 5mg | $845 | 2026-06-04 | Buy |
| ChemScene | CS-0624059 | Samalizumab 99.94% | 1073059-33-2 | 10mg | $1571 | 2026-06-04 | Buy |
| aablocks | AA0097BO | Samalizumab ≥95%(SDS-PAGE&SEC-HPLC) | 1073059-33-2 | 1mg | $570 | 2026-05-28 | Buy |
| aablocks | AA0097BO | Samalizumab ≥95%(SDS-PAGE&SEC-HPLC) | 1073059-33-2 | 5mg | $1380 | 2026-05-28 | Buy |
Samalizumab Chemical Properties, Uses, Production
Uses
Samalizumab (ALXN 6000) is a humanized monoclonal antibody that specifically binds to CD200 and blocks its ligation to the CD200 receptor (CD200R). Samalizumab can be used for multiple myeloma and B-cell chronic lymphocytic leukemia research[1].
References
[1] Daruka Mahadevan, et al. Phase I study of samalizumab in chronic lymphocytic leukemia and multiple myeloma: blockade of the immune checkpoint CD200. J Immunother Cancer. 2019 Aug 23;7(1):227. DOI:10.1186/s40425-019-0710-1
Samalizumab Preparation Products And Raw materials
Raw materials
Preparation Products
Samalizumab Suppliers
Global Suppliers ( 26)
| Supplier | Tel | Country | ProdList | Advantage | |
|---|---|---|---|---|---|
| Shanghai YuanYe Biotechnology Co., Ltd. | 15026964105 | 2881489226@qq.com | China | 89667 | 60 |
| ShangHai Biochempartner Co.,Ltd | 177-54423994 17754423994 | 2853530910@QQ.com | China | 8000 | 62 |
| Nanjing Leon Biological Technology Co., Ltd. | 025-84523390 -127; 17705183659 | sales@njleonbiotech.com | China | 5501 | 55 |
| Nanjing Peptide Biotech Ltd. | 025-58361106-805 15951641583 | zhao.xu@njpeptide.com | China | 9976 | 55 |
| Nanjing Meihao Pharmaceutical Technology Co., Ltd. | meitaochem@126.com | meitaochem@126.com | China | 19087 | 58 |
| Guangzhou Hongyuan Chemical Co.,Ltd | 15817493340 | 981810490@qq.com | China | 1577 | 58 |
| Wuhan Chemstan Biotechnology Co., Ltd. | 027-65317797 15926423062 | 422450190@qq.com | China | 10305 | 58 |
| Biolab Reagents | 027-65279366 18108604356 | products@biolabreagent.com | China | 9864 | 58 |
| Wuhan Jingkangen Biomedical Technology Co., Ltd | 13720134139 086-15871494362 13720134139 | orders@jknbiochem.com | China | 7283 | 58 |
| Shanghai Yifei Biotechnology Co. , Ltd. | 021-65675885 18964387627 | customer_service@efebio.com | China | 11963 | 58 |
1073059-33-2 (Samalizumab) Related Search:
Samalizumab
Research Grade Samalizumab (DHE30301)
Research Grade Samalizumab
Samalizumab (anti-CD200)
1073059-33-2




